Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Urasaki

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Japanese Journal of Cancer Research : Gann|June 1, 1994
Circumvention of daunorubicin resistance by a new tamoxifen derivative, toremifene, in multidrug-resistant cell lineY Urasaki, T Ueda, T Nakamura
Cancer Research|December 16, 2000
Activity of a novel camptothecin analogue, homocamptothecin, in camptothecin-resistant cell lines with topoisomerase I alterationsY Urasaki, Y Takebayashi, Y Pommier
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2001
Ecteinascidin 743 induces protein-linked DNA breaks in human colon carcinoma HCT116 cells and is cytotoxic independently of topoisomerase I expressionY Takebayashi, F Goldwasser, Y Urasaki, et al.
Cancer Research|February 24, 2001
Simultaneous treatment with 1-beta-D-arabinofuranosylcytosine and daunorubicin induces cross-resistance to both drugs due to a combination-specific mechanism in HL60 cellsH Takemura, Y Urasaki, A Yoshida, et al.
Journal of Bacteriology|April 1, 1990
Organization of the replication control region of plasmid ColIb-P9C Hama, T Takizawa, H Moriwaki, et al.
Journal of Pharmacobio-Dynamics|December 1, 1981
Protein binding effects of salivary excretion of phenobarbital in dogsJ Watanabe, Y Nakase, Y Urasaki, et al.
Journal of Pharmacobio-Dynamics|May 1, 1981
Excretion of indomethacin into saliva following intravenous administration to dogsJ Watanabe, Y Urasaki, Y Nakase, et al.
Cancer Research|February 24, 2001
Use of camptothecin-resistant mammalian cell lines to evaluate the role of topoisomerase I in the antiproliferative activity of the indolocarbazole, NB-506, and its topoisomerase I binding siteY Urasaki, G Laco, Y Takebayashi, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 4, 2000
Induction of topoisomerase I cleavage complexes by 1-beta -D-arabinofuranosylcytosine (ara-C) in vitro and in ara-C-treated cellsP Pourquier, Y Takebayashi, Y Urasaki, et al.
Leukemia Research|December 1, 1994
Influence of idarubicinol on the antileukemic effect of idarubicinT Fukushima, Y Kawai, Y Urasaki, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Japanese Journal of Cancer Research : Gann|June 1, 1994
Circumvention of daunorubicin resistance by a new tamoxifen derivative, toremifene, in multidrug-resistant cell lineY Urasaki, T Ueda, T Nakamura
Cancer Research|December 16, 2000
Activity of a novel camptothecin analogue, homocamptothecin, in camptothecin-resistant cell lines with topoisomerase I alterationsY Urasaki, Y Takebayashi, Y Pommier
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2001
Ecteinascidin 743 induces protein-linked DNA breaks in human colon carcinoma HCT116 cells and is cytotoxic independently of topoisomerase I expressionY Takebayashi, F Goldwasser, Y Urasaki, et al.
Cancer Research|February 24, 2001
Simultaneous treatment with 1-beta-D-arabinofuranosylcytosine and daunorubicin induces cross-resistance to both drugs due to a combination-specific mechanism in HL60 cellsH Takemura, Y Urasaki, A Yoshida, et al.
Journal of Bacteriology|April 1, 1990
Organization of the replication control region of plasmid ColIb-P9C Hama, T Takizawa, H Moriwaki, et al.
Journal of Pharmacobio-Dynamics|December 1, 1981
Protein binding effects of salivary excretion of phenobarbital in dogsJ Watanabe, Y Nakase, Y Urasaki, et al.
Journal of Pharmacobio-Dynamics|May 1, 1981
Excretion of indomethacin into saliva following intravenous administration to dogsJ Watanabe, Y Urasaki, Y Nakase, et al.
Cancer Research|February 24, 2001
Use of camptothecin-resistant mammalian cell lines to evaluate the role of topoisomerase I in the antiproliferative activity of the indolocarbazole, NB-506, and its topoisomerase I binding siteY Urasaki, G Laco, Y Takebayashi, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 4, 2000
Induction of topoisomerase I cleavage complexes by 1-beta -D-arabinofuranosylcytosine (ara-C) in vitro and in ara-C-treated cellsP Pourquier, Y Takebayashi, Y Urasaki, et al.
Leukemia Research|December 1, 1994
Influence of idarubicinol on the antileukemic effect of idarubicinT Fukushima, Y Kawai, Y Urasaki, et al.
Pageof 3